IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes

20252 citationsJournal Articlegreen Open Access

Authors

URL: https://www.clinicaltrials.gov; Unique identifier: NCT04826159.

Published in: Circulation

Volume 153, Issue 8, pp. 550-563

Field-Weighted Citation Impact: 2.53